As we continue to fight COVID-19 in the United States, SCDAA is compiling resources to assist the sickle cell community during the pandemic. The Centers for Disease Control and Prevention (CDC) lists sickle cell disease (SCD) as one of the populations vulnerable to severe COVID-19. SCDAA provides support to patients and CBOs assisting SCD patients during this time.
Based on current information, SCDAA recommends that people with sickle cell disease receive COVID-19 vaccination. Read SCDAA’s Statement on COVID-19 Vaccines (Updated 9/24/21).
COVID-19 Resources
- VAX FACTS: Real Talk About Sickle Cell & the COVID-19 Vaccine
- Greater Than COVID – The Conversation
- COVID-19 Vaccination Toolkits
- COVID-19 Toolkit for Older Adults & People at Higher Risk
- COVID-19 Vaccine
- COVID-19 CDC CBO Slide Deck
In addition, SCDAA’s Medical and Research Advisory Committee is committed to providing up-to-date information and developments regarding the virus, the vaccine and more. View their advisories and recommendations for SCD patients and their caregivers below.
MARAC Advisory Statement: Update About COVID-19
-December 23, 2021
MARAC Advisory Statement Update About COVID-19 Vaccines
-September 21, 2021
MARAC Issues Updated COVID-19 Guidance
-August 21, 2021
MARAC Advisory Statement: COVID-19 Vaccines
-December 15, 2020
MARAC Advisory Statement on Post-secondary and Boarding School Education in the Age of COVID-19
-July 31, 2020
MARAC Advisory Statement for SCD Patients Who are Teachers, Administrators, and Other Support Staff during School Reopening
-July 31, 2020
SCDAA MARAC Position on 2020 School Reopening
-July 27, 2020
MARAC Advisory Statement Regarding SCD Patients during the time of “Reopening” the U.S. Economy
-April 30, 2020
Sickle Cell Disease and COVID-19: Provider Advisory
-March 18, 2020
Health Alert for People with Sickle Cell Disease and their Caregivers
-March 17, 2020